Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CRON
CRON logo

CRON Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.880
Open
2.840
VWAP
2.84
Vol
1.34M
Mkt Cap
1.06B
Low
2.800
Amount
3.80M
EV/EBITDA(TTM)
233.06
Total Shares
373.66M
EV
292.03M
EV/OCF(TTM)
7.51
P/S(TTM)
6.82
Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company's diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.
Show More

Events Timeline

(ET)
2026-05-11
07:50:00
Cronos Reports Q1 Revenue of $45.21M
select
2026-04-23 (ET)
2026-04-23
13:10:00
Roth Capital: Cannabis Products Rescheduled to Schedule 3
select
2026-04-23
10:30:00
Trump Orders Medical Marijuana Products to Schedule III
select
2026-04-23
10:00:00
Trump Signs Order to Reschedule Medical Marijuana to Schedule III
select
link
2026-04-22 (ET)
2026-04-22
12:00:00
Trump Administration Expected to Reclassify Cannabis on Wednesday
select
link
2026-03-19 (ET)
2026-03-19
11:20:00
Representative Proposes Bill to Protect Legal Cannabis Businesses
select
link
2026-03-17 (ET)
2026-03-17
08:50:00
Significant Increases in Borrow Rates Among Liquid Option Names
select
2026-03-11 (ET)
2026-03-11
08:50:00
Significant Borrow Rate Increases Among Liquid Option Names
select

News

seekingalpha
9.5
05-12seekingalpha
Cronos Group Reports Record Q1 2026 Earnings Driven by International Growth
  • International Market Strength: Cronos Group achieved a record net revenue of $45.2 million in Q1 2026, reflecting a 40% year-over-year increase, with significant contributions from international markets, showcasing the company's potential for global expansion and competitiveness.
  • Canadian Market Share Gains: The Spinach brand ranked #1 across all vape formats with a 9.8% market share and held an 11.1% share in vape cartridges, indicating the company's leadership position and product popularity in the Canadian market.
  • Acquisition Progress: The company expects to complete the acquisition of CanAdelaar in summer 2026, which will position it prominently in Europe's adult-use cannabis market, further enhancing its international business footprint.
  • Capital Return Program: Cronos announced a renewed $50 million share repurchase program, coupled with its $822 million cash reserves, demonstrating the company's flexibility in capital allocation and commitment to shareholder returns.
NASDAQ.COM
9.5
05-11NASDAQ.COM
Cronos Group Reports First Quarter Earnings Growth
  • Significant Earnings Increase: Cronos Group reported a first-quarter profit of $13.75 million, translating to $0.04 per share, a substantial rise from last year's $6.12 million and $0.02 per share, indicating a marked improvement in the company's profitability.
  • Strong Revenue Growth: The company's revenue surged by 40.1% to $45.21 million compared to $32.26 million last year, reflecting robust market demand and the effectiveness of its sales strategies.
  • Market Performance Recovery: With both revenue and earnings growth, Cronos Group demonstrates stronger resilience in a competitive market, potentially attracting more investor interest in its future growth prospects.
  • Improved Financial Health: The ongoing revenue and profitability enhancements suggest that Cronos Group's financial health is improving, laying a solid foundation for future expansion and investment opportunities.
Newsfilter
9.5
05-11Newsfilter
Cronos Group Reports Record Q1 2026 Revenue and Profit
  • Significant Revenue Growth: In Q1 2026, Cronos Group achieved net revenue of $45.2 million, a 40% year-over-year increase, primarily driven by strong sales in Israel and other countries, highlighting the company's robust growth potential in international markets.
  • Improved Gross Margin: The gross profit for Q1 was $19.2 million, reflecting a 39% increase from the previous year, driven by higher average sales prices and increased sales volumes, further solidifying the company's competitive position in the market.
  • Leading Market Share: The Spinach® brand captured the #1 position in the Canadian vape market for the first time with a 9.8% market share, while maintaining its top position in edibles, showcasing the strength of its brand portfolio and innovation capabilities.
  • Strong Financial Position: As of Q1 2026, Cronos Group reported cash and cash equivalents of $822 million, demonstrating the company's financial strength and flexibility for future investments and expansions.
seekingalpha
9.5
05-08seekingalpha
Cronos Group to Announce Q1 Earnings on May 11
  • Earnings Announcement: Cronos Group is set to release its Q1 2023 earnings on May 11 before market open, with consensus EPS estimated at $0.01 and revenue projected at $42.29 million, reflecting a robust 31.1% year-over-year growth that will provide critical insights into the company's financial health.
  • Positive Market Reaction: Cannabis stocks are experiencing a surge following the DEA's rescheduling move, and as a key player in the industry, Cronos may benefit from heightened market sentiment, potentially driving its stock price upward.
  • International Expansion Strategy: Cronos is actively pursuing its European expansion and aims to stabilize margins through the acquisition of CanAdelaar, a strategy that will enhance its competitiveness in international markets and support sustainable growth.
  • Strong Financial Position: Despite market fluctuations, Cronos Group maintains a strong balance sheet, indicating its relative undervaluation in the industry, which is likely to attract increased investor interest moving forward.
Newsfilter
5.0
05-06Newsfilter
Cronos Launches New Spinach STIX® Pre-Rolls Across Canada
  • Growing Market Demand: Spinach STIX®, Cronos' latest cylindrical pre-roll, is designed to meet surging consumer interest in this popular format, with the pre-roll category accounting for over 33% of retail sales in the Canadian cannabis market, indicating strong market potential.
  • Impressive Sales Figures: In March 2026, cylindrical pre-rolls generated over $17 million in Canadian retail sales, reflecting consumer preferences for portable, even-burning, and smooth smoking experiences, which further drives growth in this category.
  • Product Expansion Strategy: Spinach STIX® is now available in multiple provinces including Alberta, British Columbia, and Manitoba, aiming to meet evolving consumer preferences by offering a sleeker pre-roll option, thereby enhancing the brand's competitive position in the market.
  • Strengthening Brand Positioning: Cronos is focused on optimizing its high-quality product lineup, positioning Spinach® as one of the most reliable cannabis brands in Canada, thereby solidifying its leadership in the rapidly growing market.
Newsfilter
1.0
04-29Newsfilter
Cronos Group Announces 2026 Annual Shareholders Meeting Details
  • Meeting Schedule: Cronos Group will hold its 2026 Annual Meeting of Shareholders on June 18, 2026, at 11:00 a.m. ET in a virtual format, ensuring equal participation for all registered shareholders and proxyholders.
  • Participation Details: The meeting will be conducted via live audio webcast, allowing shareholders to ask questions and vote online, which enhances shareholder engagement and interaction, thereby improving corporate governance transparency.
  • Replay Availability: A replay of the meeting will be accessible approximately 24 hours after its conclusion in the investor relations section of the company's website, ensuring that shareholders who could not attend live can still access the meeting content.
  • Company Overview: Cronos is an innovative global cannabis company focused on scaling leading consumer goods products through R&D and innovation, aiming to build an iconic brand portfolio to elevate the consumer experience.
Wall Street analysts forecast CRON stock price to rise
2 Analyst Rating
Wall Street analysts forecast CRON stock price to rise
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
2.30
Averages
2.72
High
3.14
Current: 0.000
sliders
Low
2.30
Averages
2.72
High
3.14
TD Securities
NULL
to
Buy
maintain
AI Analysis
2026-05-12
Reason
TD Securities
Price Target
AI Analysis
2026-05-12
maintain
NULL
to
Buy
Reason
TD Securities raised the firm's price target on Cronos Group to C$5.50 from C$4.50 and keeps a Buy rating on the shares.
TD Securities
NULL -> Buy
initiated
$4.50
2026-02-24
Reason
TD Securities
Price Target
$4.50
2026-02-24
initiated
NULL -> Buy
Reason
TD Securities initiated coverage of Cronos Group with a Buy rating and C$4.50 price target. Cronos, which has "some of the most iconic Canadian cannabis brands on the market, is well-positioned to improve profitability as it scales the top-line with a lean operating cost base and leading cultivation practices, the analyst tells investors.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CRON
Unlock Now

Valuation Metrics

The current forward P/E ratio for Cronos Group Inc (CRON.O) is 26.04, compared to its 5-year average forward P/E of 379.90. For a more detailed relative valuation and DCF analysis to assess Cronos Group Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
379.90
Current PE
26.04
Overvalued PE
1593.49
Undervalued PE
-833.68

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.42
Current EV/EBITDA
-96.77
Overvalued EV/EBITDA
9.88
Undervalued EV/EBITDA
-12.72

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
9.28
Current PS
3.54
Overvalued PS
15.66
Undervalued PS
2.90

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

how is cannibis securities doing today
Intellectia · 8 candidates
Market Cap: >= 100.00MPrice: >= $1.00Themes: The Cannabis IndustryMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
CGC logo
CGC
Canopy Growth Corp
511.04M
TLRY logo
TLRY
Tilray Brands Inc
803.02M
SNDL logo
SNDL
SNDL Inc
391.39M
VFF logo
VFF
Village Farms International Inc
328.97M
ACB logo
ACB
Aurora Cannabis Inc
201.89M
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.49B
Give me the top 5 cannabis companies
Intellectia · 4 candidates
Market Cap: >= 500.00MRevenue Ttm: >= 100.00MRegion: USThemes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.52B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.43B
CRON logo
CRON
Cronos Group Inc
947.63M
TLRY logo
TLRY
Tilray Brands Inc
736.32M
Should I Buy cannabis stocks?
Intellectia · 9 candidates
Market Cap: >= 50.00MThemes: The Cannabis IndustryList Exchange: XNYS, XNASMonthly Average Dollar Volume: >= 100,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
what cannabis stocks would you buy?
Intellectia · 4 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryQuarter Revenue Yoy Growth: >= 0.0%Monthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
SNDL logo
SNDL
SNDL Inc
386.25M
ACB logo
ACB
Aurora Cannabis Inc
204.15M
cannabis
Intellectia · 8 candidates
Market Cap: >= 200.00MPrice: >= $1.00Themes: The Cannabis IndustryIs Optionable: TrueMonthly Average Dollar Volume: >= 200,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
4.06B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.29B
CRON logo
CRON
Cronos Group Inc
1.01B
TLRY logo
TLRY
Tilray Brands Inc
874.97M
CGC logo
CGC
Canopy Growth Corp
440.50M
SNDL logo
SNDL
SNDL Inc
386.25M
best penny stocks to buy
Intellectia · 45 candidates
Market Cap: 50.00M - 1000.00MRegion: USPrice: $0.20 - $5.00Eps Ttm: >= 0Beta: ModerateRisk, HighRiskList Exchange: XNYS, XNAS, XASEMonthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
HIVE logo
HIVE
HIVE Digital Technologies Ltd
695.26M
REI logo
REI
Ring Energy Inc
246.60M
GAU logo
GAU
Galiano Gold Inc
691.04M
LDI logo
LDI
loanDepot Inc
726.45M
ITRG logo
ITRG
Integra Resources Corp
671.92M
MVST logo
MVST
Microvast Holdings Inc
859.84M
marijuana stocks
Intellectia · 8 candidates
Market Cap: >= 200.00MRegion: US, CanadaPrice: >= $1.00Themes: The Cannabis IndustryList Exchange: XNYS, XNAS, XASEIs Optionable: TrueMonthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
CGC logo
CGC
Canopy Growth Corp
460.70M
SNDL logo
SNDL
SNDL Inc
406.85M
which. cannabisindustry should I invest in
Intellectia · 2 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryWeekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 0.0%
Ticker
Name
Market Cap$
top bottom
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M
whats the best penny stocks to invest into
Intellectia · 25 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Eps Ttm: >= 0Weekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
CRON logo
CRON
Cronos Group Inc
999.35M
GOGO logo
GOGO
Gogo Inc
642.50M
TALK logo
TALK
Talkspace Inc
632.81M
DDL logo
DDL
Dingdong (Cayman) Ltd
602.62M
NPWR logo
NPWR
NET Power Inc
575.35M
VTEX logo
VTEX
VTEX
573.92M
Cannibus stocks
Intellectia · 4 candidates
Market Cap: >= 500.00MThemes: The Cannabis IndustryBeta: ModerateRisk, HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SMG logo
SMG
Scotts Miracle-Gro Co
3.70B
IIPR logo
IIPR
Innovative Industrial Properties Inc
1.41B
TLRY logo
TLRY
Tilray Brands Inc
1.01B
CRON logo
CRON
Cronos Group Inc
999.35M

Whales Holding CRON

A
Altria Group, Inc.
Holding
CRON
+1.91%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Cronos Group Inc (CRON) stock price today?

The current price of CRON is 2.84 USD — it has increased 0

What is Cronos Group Inc (CRON)'s business?

Cronos Group Inc. is a global cannabinoid company engaged in building disruptive intellectual property by advancing cannabis research, technology and product development. The Company's diverse international brand portfolio includes Spinach, PEACE NATURALS and Lord Jones. Spinach is a mainstream adult-use cannabis brand with a portfolio that includes cannabinoid products in a wide range of formats, including dried flower, pre-rolls, vaporizers, edibles and tinctures. Lord Jones is a premium adult-use cannabis brand. The Lord Jones brand portfolio includes cannabis products in the pre-roll, vaporizer and edible categories. Lord Jones Ice Water Hash Fusions pre-rolls feature flower and terpene-rich ice water hash and are fitted with a branded ceramic tip. PEACE NATURALS is a global medical brand engaged in producing cannabis products. The Company distributes products under the PEACE NATURALS brand for the Canadian market and the Israeli, German, and United Kingdom medical markets.

What is the price predicton of CRON Stock?

Wall Street analysts forecast CRON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CRON is2.72 USD with a low forecast of 2.30 USD and a high forecast of 3.14 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Cronos Group Inc (CRON)'s revenue for the last quarter?

Cronos Group Inc revenue for the last quarter amounts to 45.21M USD, increased 40.13

What is Cronos Group Inc (CRON)'s earnings per share (EPS) for the last quarter?

Cronos Group Inc. EPS for the last quarter amounts to 0.04 USD, increased 100.00

How many employees does Cronos Group Inc (CRON). have?

Cronos Group Inc (CRON) has 356 emplpoyees as of May 30 2026.

What is Cronos Group Inc (CRON) market cap?

Today CRON has the market capitalization of 1.06B USD.